131 related articles for article (PubMed ID: 34581783)
1. Bilineal evolution of a U2AF1-mutated clone associated with acquisition of distinct secondary mutations.
Montgomery ND; Galeotti J; Johnson SM; Commander L; Weimer ET; Chandra PK; Nazir T; Alexander TB; Zeidner JF; Foster MC
Blood Adv; 2021 Dec; 5(24):5612-5616. PubMed ID: 34581783
[TBL] [Abstract][Full Text] [Related]
2. Clonal evolution revealed by whole genome sequencing in a case of primary myelofibrosis transformed to secondary acute myeloid leukemia.
Engle EK; Fisher DA; Miller CA; McLellan MD; Fulton RS; Moore DM; Wilson RK; Ley TJ; Oh ST
Leukemia; 2015 Apr; 29(4):869-76. PubMed ID: 25252869
[TBL] [Abstract][Full Text] [Related]
3. Patterns of missplicing due to somatic U2AF1 mutations in myeloid neoplasms.
Przychodzen B; Jerez A; Guinta K; Sekeres MA; Padgett R; Maciejewski JP; Makishima H
Blood; 2013 Aug; 122(6):999-1006. PubMed ID: 23775717
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive genomic profiling reveals molecular subsets of
Johnson SM; Haberberger J; Galeotti J; Ramkissoon L; Coombs CC; Richardson DR; Foster MC; Duncan D; Montgomery ND; Ferguson NL; Zeidner JF
Leuk Lymphoma; 2024 Feb; 65(2):209-218. PubMed ID: 37921062
[TBL] [Abstract][Full Text] [Related]
5. Mutational patterns and their correlation to CHIP-related mutations and age in hematological malignancies.
Stengel A; Baer C; Walter W; Meggendorfer M; Kern W; Haferlach T; Haferlach C
Blood Adv; 2021 Nov; 5(21):4426-4434. PubMed ID: 34570179
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathologic characterisation of myeloid neoplasms with concurrent spliceosome mutations and myeloproliferative-neoplasm-associated mutations.
Liu YC; Illar GM; Bailey NG
J Clin Pathol; 2020 Nov; 73(11):728-736. PubMed ID: 32217616
[TBL] [Abstract][Full Text] [Related]
7. Alteration of the SETBP1 gene and splicing pathway genes SF3B1, U2AF1, and SRSF2 in childhood acute myeloid leukemia.
Choi HW; Kim HR; Baek HJ; Kook H; Cho D; Shin JH; Suh SP; Ryang DW; Shin MG
Ann Lab Med; 2015 Jan; 35(1):118-22. PubMed ID: 25553291
[TBL] [Abstract][Full Text] [Related]
8. Clinical Evaluation of a Novel Nine-Gene Panel for Ion Torrent PGM Sequencing of Myeloid Malignancies.
Ivanova M; Shivarov V; Pavlov I; Lilakos K; Naumova E
Mol Diagn Ther; 2016 Feb; 20(1):27-32. PubMed ID: 26476543
[TBL] [Abstract][Full Text] [Related]
9. Mutational landscape of patients with acute myeloid leukemia or myelodysplastic syndromes in the context of RUNX1 mutation.
Wang K; Zhou F; Cai X; Chao H; Zhang R; Chen S
Hematology; 2020 Dec; 25(1):211-218. PubMed ID: 32476595
[No Abstract] [Full Text] [Related]
10. Coexisting and cooperating mutations in NPM1-mutated acute myeloid leukemia.
Patel JL; Schumacher JA; Frizzell K; Sorrells S; Shen W; Clayton A; Jattani R; Kelley TW
Leuk Res; 2017 May; 56():7-12. PubMed ID: 28152414
[TBL] [Abstract][Full Text] [Related]
11. Acute myeloid leukemia ontogeny is defined by distinct somatic mutations.
Lindsley RC; Mar BG; Mazzola E; Grauman PV; Shareef S; Allen SL; Pigneux A; Wetzler M; Stuart RK; Erba HP; Damon LE; Powell BL; Lindeman N; Steensma DP; Wadleigh M; DeAngelo DJ; Neuberg D; Stone RM; Ebert BL
Blood; 2015 Feb; 125(9):1367-76. PubMed ID: 25550361
[TBL] [Abstract][Full Text] [Related]
12. Mutational spectrum and prognosis in NRAS-mutated acute myeloid leukemia.
Wang S; Wu Z; Li T; Li Y; Wang W; Hao Q; Xie X; Wan D; Jiang Z; Wang C; Liu Y
Sci Rep; 2020 Jul; 10(1):12152. PubMed ID: 32699322
[TBL] [Abstract][Full Text] [Related]
13. The Biological and Clinical Consequences of RNA Splicing Factor U2AF1 Mutation in Myeloid Malignancies.
Zhao Y; Cai W; Hua Y; Yang X; Zhou J
Cancers (Basel); 2022 Sep; 14(18):. PubMed ID: 36139566
[TBL] [Abstract][Full Text] [Related]
14. Clonal hierarchy of main molecular lesions in acute myeloid leukaemia.
Herudkova Z; Culen M; Folta A; Jeziskova I; Cerna J; Loja T; Tom N; Smejkal J; Semerad L; Dvorakova D; Mayer J; Racil Z
Br J Haematol; 2020 Aug; 190(4):562-572. PubMed ID: 31822038
[TBL] [Abstract][Full Text] [Related]
15. [Mutation analysis of 77 patients with normal-karyotype myelodysplastic syndrome].
Qin W; Chen M; Cai X; Chao H; Liu J; Jiang N; Zhou M; Lu X; Chen S; Zhang R; He C; Wang Q
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2019 Sep; 36(9):857-861. PubMed ID: 31515775
[TBL] [Abstract][Full Text] [Related]
16. Mutant U2AF1 Expression Alters Hematopoiesis and Pre-mRNA Splicing In Vivo.
Shirai CL; Ley JN; White BS; Kim S; Tibbitts J; Shao J; Ndonwi M; Wadugu B; Duncavage EJ; Okeyo-Owuor T; Liu T; Griffith M; McGrath S; Magrini V; Fulton RS; Fronick C; O'Laughlin M; Graubert TA; Walter MJ
Cancer Cell; 2015 May; 27(5):631-43. PubMed ID: 25965570
[TBL] [Abstract][Full Text] [Related]
17. Impaired hematopoiesis and leukemia development in mice with a conditional knock-in allele of a mutant splicing factor gene
Fei DL; Zhen T; Durham B; Ferrarone J; Zhang T; Garrett L; Yoshimi A; Abdel-Wahab O; Bradley RK; Liu P; Varmus H
Proc Natl Acad Sci U S A; 2018 Oct; 115(44):E10437-E10446. PubMed ID: 30322915
[TBL] [Abstract][Full Text] [Related]
18. Differential U2AF1 mutation sites, burden and co-mutation genes can predict prognosis in patients with myelodysplastic syndrome.
Wang H; Guo Y; Dong Z; Li T; Xie X; Wan D; Jiang Z; Yu J; Guo R
Sci Rep; 2020 Oct; 10(1):18622. PubMed ID: 33122737
[TBL] [Abstract][Full Text] [Related]
19. Mutations in DNMT3A, U2AF1, and EZH2 identify intermediate-risk acute myeloid leukemia patients with poor outcome after CR1.
Saygin C; Hirsch C; Przychodzen B; Sekeres MA; Hamilton BK; Kalaycio M; Carraway HE; Gerds AT; Mukherjee S; Nazha A; Sobecks R; Goebel C; Abounader D; Maciejewski JP; Advani AS
Blood Cancer J; 2018 Jan; 8(1):4. PubMed ID: 29321554
[TBL] [Abstract][Full Text] [Related]
20. [Clonal evolution of myeloid malignancies].
Kon A
Rinsho Ketsueki; 2020; 61(9):1120-1129. PubMed ID: 33162507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]